| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Immunology and
Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195;
Terry Fox Laboratory, British Columbia Cancer Agency, and Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada
RasGRP1 is a guanine nucleotide exchange factor for Ras that is required for the efficient production of both CD4 and CD8 single-positive thymocytes. We found that RasGRP1 expression is rapidly up-regulated in double-negative thymocytes following pre-TCR ligation. Transgenic overexpression of RasGRP1 compensated for deficient pre-TCR signaling in vivo, enabling recombinase-activating gene 2-/- double-negative thymocytes to mature to the double-positive stage. RasGRP1 transgenic mice had a 4-fold increase in CD8 single-positive thymocytes, most of which had atypically low levels of CD3. The RasGRP1 transgene lowered the threshold of TCR signaling needed to initiate proliferation of single-positive thymocytes, with this effect being particularly evident among CD8 single-positive cells. In 3-day cultures, TCR stimulation via anti-CD3 caused a 10-fold increase in the ratio of CD8 to CD4 thymocytes among RasGRP1 transgenic vs nontransgenic thymocytes. These results demonstrate that in addition to driving the double-negative to double-positive transition, increased expression of RasGRP1 selectively increases CD8 single-positive thymocyte numbers and enhances their responsiveness to TCR signaling.
This article has been cited by other articles:
|
|
 |
|
  H Q Qu, S F A Grant, J P Bradfield, C Kim, E Frackelton, H Hakonarson, and C Polychronakos Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies J. Med. Genet., August 1, 2009; 46(8): 553 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yasuda, R. L. Stevens, T. Terada, M. Takeda, T. Hashimoto, J. Fukae, T. Horita, H. Kataoka, T. Atsumi, and T. Koike Defective Expression of Ras Guanyl Nucleotide-Releasing Protein 1 in a Subset of Patients with Systemic Lupus Erythematosus J. Immunol., October 1, 2007; 179(7): 4890 - 4900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Beaulieu, B. Zahedi, R. E. Goulding, G. Tazmini, K. V. Anthony, S. L. Omeis, D. R. de Jong, and R. J. Kay Regulation of RasGRP1 by B Cell Antigen Receptor Requires Cooperativity between Three Domains Controlling Translocation to the Plasma Membrane Mol. Biol. Cell, August 1, 2007; 18(8): 3156 - 3168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Trampont, L. Zhang, and K. S. Ravichandran ShcA Mediates the Dominant Pathway to Extracellular Signal-Regulated Kinase Activation during Early Thymic Development Mol. Cell. Biol., December 1, 2006; 26(23): 9035 - 9044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yu, K. Bauer, P. Wernhoff, D. Koczan, S. Moller, H.-J. Thiesen, and S. M. Ibrahim Fine Mapping of Collagen-Induced Arthritis Quantitative Trait Loci in an Advanced Intercross Line J. Immunol., November 15, 2006; 177(10): 7042 - 7049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Guilbault and R. J. Kay RasGRP1 Sensitizes an Immature B Cell Line to Antigen Receptor-induced Apoptosis J. Biol. Chem., May 7, 2004; 279(19): 19523 - 19530. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
